13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...10, 11, 12, 13, 14, ...17, 18, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
1:15 pm
Purchase
2021-12-31 13G Alpine Immune Sciences, Inc.
ALPN
BIOTECHNOLOGY VALUE FUND L P 1,589,495
5.400%
451,731increase
(+39.70%)
Filing
History
2022-02-14
1:12 pm
Purchase
2021-12-31 13G Syndax Pharmaceuticals, Inc.
SNDX
BIOTECHNOLOGY VALUE FUND L P 4,931,879
8.900%
1,221,190increase
(+32.91%)
Filing
History
2022-02-14
1:05 pm
Purchase
2021-12-31 13G Regulus Therapeutics Inc.
RGLS
BIOTECHNOLOGY VALUE FUND L P 966,124
9.990%
261,077increase
(+37.03%)
Filing
History
2022-02-14
1:02 pm
Purchase
2021-12-31 13G X4 Pharmaceuticals, Inc.
XFOR
BIOTECHNOLOGY VALUE FUND L P 100,922
9.990%
43,602increase
(+76.07%)
Filing
History
2022-02-14
12:59 pm
Sale
2021-12-31 13G Forward Pharma A/S
FWPAY
BIOTECHNOLOGY VALUE FUND L P 25,239
7.300%
-10,532decrease
(-29.44%)
Filing
History
2022-02-14
12:56 pm
Purchase
2021-12-31 13G Bionomics Limited
BNOX
BIOTECHNOLOGY VALUE FUND L P 14,174,157
13.000%
14,174,157increase
(New Position)
Filing
History
2022-02-14
12:53 pm
Purchase
2021-12-31 13G GH Research PLC
GHRS
BIOTECHNOLOGY VALUE FUND L P 9,275,158
17.800%
9,275,158increase
(New Position)
Filing
History
2022-02-11
9:11 pm
Purchase
2021-12-31 13G Repare Therapeutics Inc.
RPTX
BIOTECHNOLOGY VALUE FUND L P 4,858,761
11.600%
1,136,363increase
(+30.53%)
Filing
History
2022-02-11
9:03 pm
Purchase
2021-12-31 13G Protagonist Therapeutics, Inc.
PTGX
BIOTECHNOLOGY VALUE FUND L P 4,891,945
9.990%
616,980increase
(+14.43%)
Filing
History
2022-02-11
8:57 pm
Sale
2021-12-31 13G Revolution Medicines, Inc.
RVMD
BIOTECHNOLOGY VALUE FUND L P 1,810,549
2.500%
-1,946,500decrease
(-51.81%)
Filing
History
2022-02-11
8:51 pm
Purchase
2021-12-31 13G POINT Biopharma Global Inc.
PNT
BIOTECHNOLOGY VALUE FUND L P 2,920,526
3.200%
2,920,526increase
(New Position)
Filing
History
2022-02-11
8:33 pm
Purchase
2021-12-31 13G Lexicon Pharmaceuticals, Inc.
LXRX
BIOTECHNOLOGY VALUE FUND L P 14,360,000
9.600%
3,397,000increase
(+30.99%)
Filing
History
2022-02-11
8:19 pm
Sale
2021-12-31 13G IDEAYA Biosciences, Inc.
IDYA
BIOTECHNOLOGY VALUE FUND L P 559
1.000%
-1,787,000decrease
(-99.97%)
Filing
History
2022-02-11
7:54 pm
Purchase
2021-12-31 13G Genocea Biosciences, Inc.
GNCA
BIOTECHNOLOGY VALUE FUND L P 5,930,353
9.990%
644,804increase
(+12.20%)
Filing
History
2022-02-11
7:44 pm
Sale
2021-12-31 13G GRITSTONE BIO INC
GRTSQ
BIOTECHNOLOGY VALUE FUND L P 0
0.000%
-2,695,418decrease
(Position Closed)
Filing
History
2022-02-11
7:41 pm
Sale
2021-12-31 13G Forte Biosciences, Inc.
FBRX
BIOTECHNOLOGY VALUE FUND L P 0
0.000%
-53,770decrease
(Position Closed)
Filing
History
2022-02-11
7:33 pm
Sale
2021-12-31 13G Whitehawk Therapeutics Inc
WHWK
BIOTECHNOLOGY VALUE FUND L P 899,392
4.300%
-247,660decrease
(-21.59%)
Filing
History
2022-02-11
7:30 pm
Sale
2021-12-31 13G Corvus Pharmaceuticals, Inc.
CRVS
BIOTECHNOLOGY VALUE FUND L P 1,370,947
3.000%
-1,527,850decrease
(-52.71%)
Filing
History
2022-02-11
7:22 pm
Sale
2021-12-31 13G Merus N.V.
MRUS
BIOTECHNOLOGY VALUE FUND L P 4,135,071
9.600%
-925,000decrease
(-18.28%)
Filing
History
2022-01-31
5:07 pm
Purchase
2022-01-27 13D Kymera Therapeutics, Inc.
KYMR
BIOTECHNOLOGY VALUE FUND L P 3,586,658
7.000%
955,996increase
(+36.34%)
Filing
History
Goto Prev, 0, 1, ...10, 11, 12, 13, 14, ...17, 18, Next